INVESTOR RELATIONS CENTER
Evotec SE
Analyst Coverage
Unternehmen |
Analyst |
Empfehlung |
Target price of Shares listed at Frankfurt Stock Exchange
(in EUR) |
Target Price of ADS listed at NASDAQ New York
(in USD) |
Datum of latest
Research Report |
BofA |
Derik de Bruin |
UNDERPERFORM |
|
4.50 D |
22 May 2024 |
Bryan Garnier & Co |
Alex Cogut |
BUY |
22.00 € |
- |
29 September 2022 |
Citigroup Inc. |
Peter Verdult |
BUY |
30.00 € |
- |
22 May 2024 |
TD Cowen |
Steven Mah |
BUY |
- |
19.00 D |
27 June 2024 |
Deutsche Bank |
Falko Friedrichs |
BUY |
12.00 € |
- |
22 May 2024 |
H.C. Wainwright & Co. |
Douglas Tsao |
BUY |
- |
14.00 D |
31 August 2023 |
IntronHealth |
Naresh Chouhan |
SELL |
7.35 € |
|
17 June 2024 |
Jefferies |
Peter Welford |
BUY |
16.00 € |
- |
22 May 2024 |
Morgan Stanley |
James Quigley |
OVERWEIGHT |
28.00 € |
- |
22 May 2024 |
ODDO BHF |
Stephan Wulf |
OUTPERFORM |
13.50 € |
- |
22 May 2024 |
Royal Bank of Canada (RBC) |
Zoe Karamanoli |
OUTPERFOM |
16.00 € |
- |
10 June 2024 |
Rx Securities |
Dr Samir Devani |
BUY |
20.00 € |
- |
12 June 2024 |
Van Lanschot Kempen |
Sebastiaan van der Schoot |
BUY |
15.00 € |
- |
07 May 2024 |
Warburg Research |
Dr Christian Ehmann |
BUY |
18.00 € |
- |
22 May 2024 |
Average target price |
|
|
17.95 € |
12.50 D |
|
Diese Inhalte werden Ihnen präsentiert von der
![EQS Group AG](/ircenter_moreir/img/EQS.gif)
.